Purpose: Atherosclerotic plaque vulnerability is a systemic phenomenon and is often associated with severe plaque infiltration with inflammatory cells. 18-Fluoro-deoxyglucose (FDG) accumulates in inflammatory cells of atherosclerotic plaques. The aim of this study was to assess whether 1) FDG uptake in the aorta and carotid arteries measured by positron emission tomography (PET) is higher in patients with acute coronary syndromes (ACS) than in patients with stable coronary artery disease (CAD) and; 2) associated with morphological markers of plaque instability detected with computed tomography angiography (CTA).
017* Echocardiographic factors determining immediate results of percutaneous mitral balloon commissurotomy
Leila Bazdah, Hédi Baccar, Wejdène Ouechtati, Hbib Ben Ahmed, Slim Sidhom, Sami Marouène, Imène Fradi Hôpital Charles icolle, cardiologie, Tunis, Tunisie
Objectives: Define echocardiographic predictors of the immediateresults of percutaneous mitral balloon commissurotomy (PMC)
Methods : PMC by the Inoue balloon was attempted in 247 patients (mean age: 35 ans, 77% female) with severe mitral valve stenosis. All the patients had undergone echocardiographic examination before PMC to assess mitral anatomy, commissural calcification and to determine the Wilkins score.
Results: the mean value of Wilkins score was 7,98±1,61(range 5-13) and the mean mitral valve area (MVA) before PMC was 1±0,19cm² (range 0,5-1,4cm²) . Twenty-nine patients (11,7%) had one-commissural calcification. After PMC, the mean MVA increased to 1,79±0,34cm² (p<0,001) resulting in a success rate of 83%. Severe mitral regurgitation (MR) occured in 5 patients (2%). Wilkins score was an independent predictor of the immediate result of PMC, but if >8, this score had a weak predictive value. Commissural morphology was another independent predictor of the immediate result of PMC.
Conclusion:
Echocardiography is now the cornerstone in the assessment of mitral anatomy before PMC and should integrate Wilkins score and commissural morphology for the optimal selection of patients to PMC. *This abstract refered to topic "Valvular heart disease".
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Prevalence and impact of cardiovascular risk factors among HIVinfected patients presenting with acute myocardial infarction Background: Acute complications of atherosclerosis, such as acute myocardial infarction (AMI) are becoming more common in patients with HIV. But the risk of coronary heart disease in HIV patients is influenced both from traditional risk factors and from specific features of this disease. The aim of the present study was to examine in-hospital case fatality in HIV-infected patients with AMI. Findings: Among the 677 076 patients included, HIV-infected patients (n=1344) accounted for 0.20%. HIV patients were younger, more frequently male and more likely to smoke. Hospital mortality was 4.3% in the HIVinfected group compared with 7.0% in uninfected patients (p <0.0001), but no difference appeared between the 2 groups after matching (3.4% vs. 4.3%; p=0.1334). Based on a Cox regression model, HIV-infection was not an independent predictor of in-hospital mortality in the overall population or after matching. Among none HIV infected patients, dyslipidemia, current smoker, STEMI and coronary angioplasty were independent predictors of in-hospital mortality. 
Conclusion:
HIV-infected patients have a greater risk of myocardial infarction, but the present study demonstrated than the short-term are similar to non infected patients. Moreover, chronic kidney disease is more common in HIV-infected patients and associated with a worse prognosis. Consequently HIV care increasingly needs to incorporate strategies to manage these noninfectious co-morbidity in primary and secondary prevention. Background: The national observational study of diagnostic and interventional cardiac catheterization (ONACI) is a prospective multi-center registry of the French Society of Cardiology including all interventional cardiology procedures performed from 2004. We aimed to evaluate "real world" management of patients with coronary artery disease (CAD) in France from this registry.
Methods:
The present study is focused on data collected between 2004 and 2008. Patient demographics and co-morbidities, invasive parameters, treatment options, and procedural techniques were prospectively collected. Patients were recruited in 99 hospitals (55% of patients were hospitalized in private clinics, 45% in public institutions). Results: Over a 5-year period, a total of 298,105 patients underwent coronary angiography (CAG) and 176,166 patients underwent percutaneous coronary intervention (PCI). Diagnosis was acute coronary syndrome (ACS) in 22%, stable angina or silent ischemia in 23% and atypical chest pain in 9% of cases. Normal coronary arteries or not significant coronary lesions were found in 26% of patients. Radial access was increasingly used over the years regardless of the indication. The average number of PCI per procedure was 1.5±0.7 (range from 1.3±0.7 to 1.5±0.7) and those of stents per procedure were 1.5±0.8 (range from 1.5±0.8 to 1.6±0.8). Drug-eluting stents (DES) were used in 45% (range from 34 to 62%).
Conclusions:
Coronary anatomy is highly dependent on clinical presentation. Strategies to reduce the number of normal CAG performed for atypical chest pain should be developed. The management of ACS is associated with less radial access, more single PCI and fewer DES.
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Impact of anti-platelets dose fractionation on platelet inhibition in type 2 diabetes mellitus Redouane Saady, Denis Doyen, Emile Ferrari CHU ice, Cardiologie, ice, France
Objective: The hypothesis of the study was that increased drug administration frequency [twice daily versus once daily] may provide more effective platelet inhibition in patients with type 2 diabetes mellitus.
Methods: Twenty patients with type 2 diabetes mellitus with stable coronary artery disease were prospectively recruited. All the patients received once daily 150 mg of aspirin and clopidogrel for two weeks. Then patients were switched to aspirin and clopidogrel 75 mg twice daily for two weeks. Pharmacodynamic assessment was performed by VerifyNow system accumetrics at fifteen and thirty days.
Results: There was no difference between the antiplatelet effect produced by 150 mg of aspirin given once daily and 75 mg of aspirin given twice daily. A twice-daily dose of 75 mg of clopidogrel is associated with significantly more effective platelet inhibition on the residual assay: PRU=38.2% once daily vs 53.8% twice daily (p= 0.001) and PRU=187 once daily vs 147 twice daily (p=0.005).
Conclusions:
Increasing the frequency of clopidogrel administration to twice daily in patients with type 2 diabetes mellitus is significantly associated with more effective platelet inhibition. But our data do not support a twicedaily dose of aspirin to improve platelet response.
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Clopidogrel low response and correlation between the different tests: light transmission aggregometry, Verify ow-P2Y12 and VASP.
Gilles Lemesle (1), Jean-Baptiste Landel (2), Anne Bauters (3), Cedric Delhaye (1), Laurent Bonello (4), Arnaud Sudre (1) Background: Clopidogrel low response correlates with poor prognosis after percutaneous coronary intervention (PCI). Many biological tests are currently available to test the clopidogrel response. However, the presence of any correlation between the different tests is today poorly reported.
Methods:
In this prospective study, clopidogrel response was assessed in 100 consecutive patients. All patients were tested between 18h and 24h after a 600mg clopidogrel loading dose using 3 different tests: light transmission aggregometry with 10 µmol ADP (LTA, results expressed as platelet inhibition percentage), VerifyNow-P2Y12 (VN, results expressed as PRU) and vasodilatator stimulated phosphoprotein (VASP, results expressed as IRP). Patients under chronic clopidogrel therapy were excluded.
Results:
The mean platelet inhibition percentage, PRU value and IRP value were 38.5±13% by LTA, 178±89 PRU by VN and 52±21% by VASP. When results were analyzed as continuous variables, there was a good correlation
